{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T03:01:03Z","timestamp":1780714863435,"version":"3.54.1"},"reference-count":34,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"unspecified","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-013, 2022-PUMCH-A-039"],"award-info":[{"award-number":["2022-PUMCH-B-013, 2022-PUMCH-A-039"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2025,7,1]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to evaluate the diagnostic performance of the digital liquid chip method (DLCM) compared with indirect immunofluorescence (IIF) and chemiluminescent immunoassay (CLIA) for anti-double-stranded DNA (dsDNA) antibody detection in SLE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The retrospective study consecutively enrolled 1349 patients, including 698 with SLE and 651 with other autoimmune diseases at Peking Union Medical College Hospital. Anti-dsDNA antibodies were detected using IIF (EUROIMMUN, Luebeck, Germany), CLIA (YHLO, Shenzhen, China) and DLCM (Livzon, Zhuhai, China). The sensitivity, specificity and area under the curve (AUC) of each method and combination were compared at the recommended manufacturer cut-offs. The agreement between methods and the association between antibody levels and clinical characteristics including disease activity, complement levels and organ involvement were also evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>All methods exhibited high specificity, while IIF performed best (98.5%), significantly greater than CLIA (96.3%) and DLCM (96.6%) (p\u202f&lt;\u202f0.05). CLIA demonstrated the highest sensitivity (48.1%), outperforming IIF (36.0%) and DLCM (41.4%) (p&lt;0.001). Cohen\u2019s kappa indicated substantial positive agreement between DLCM and CLIA (\u03ba=0.67), and moderate agreement between IIF and the other methods (\u03ba=0.52\u20130.55). Combining IIF with DLCM or CLIA improved diagnosis performance, with IIF+CLIA achieving the highest sensitivity (54.0%), accuracy (74.1%) and AUC (0.75). Moreover, anti-dsDNA positivity was strongly associated with lower complement levels (C3: 0.71 vs 0.90\u2009g\/L in DLCM+ vs DLCM\u2212, p&lt;0.001) and moderate\u2013severe disease activity (65.0% DLCM positive). DLCM uniquely predicted musculoskeletal involvement (55.3% vs 44.7%, p&lt;0.01). However, the diagnostic performance for renal involvement was limited (sensitivity 46.9%, specificity 56.3%, AUC=0.52).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>DLCM demonstrated substantial agreement with CLIA and held potential for SLE diagnosis and monitoring. A multiassay strategy, using a sensitive assay like CLIA or DLCM for initial screening and a highly specific assay like IIF for confirmation, optimises diagnostic performance for anti-dsDNA antibody detection in SLE.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/lupus-2025-001608","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T09:35:20Z","timestamp":1752572120000},"page":"e001608","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical evaluation of the novel digital liquid chip method for anti-dsDNA detection in SLE"],"prefix":"10.1136","volume":"12","author":[{"given":"Yina","family":"Bai","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9161-3512","authenticated-orcid":false,"given":"Rui","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, People's Republic of China"},{"name":"Eight-year Medical Doctor Program, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiyuan","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinping","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3883-2318","authenticated-orcid":false,"given":"Xiaofeng","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4171-9738","authenticated-orcid":false,"given":"Mengtao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaojun","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, People's Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"key":"2026010700553062000_12.2.e001608.1","doi-asserted-by":"publisher","DOI":"10.7326\/AITC202006020"},{"key":"2026010700553062000_12.2.e001608.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30237-5"},{"key":"2026010700553062000_12.2.e001608.3","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.151"},{"key":"2026010700553062000_12.2.e001608.4","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780251101"},{"key":"2026010700553062000_12.2.e001608.5","doi-asserted-by":"crossref","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2026010700553062000_12.2.e001608.6","doi-asserted-by":"publisher","DOI":"10.1002\/art.34473"},{"key":"2026010700553062000_12.2.e001608.7","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214819"},{"key":"2026010700553062000_12.2.e001608.8","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/809389","article-title":"Chinese SLE treatment and research group registry: III. association of autoantibodies with clinical manifestations in Chinese patients with systemic lupus erythematosus","volume":"2014","author":"Li","year":"2014","journal-title":"J Immunol Res"},{"key":"2026010700553062000_12.2.e001608.9","doi-asserted-by":"publisher","DOI":"10.2478\/rir-2021-0001"},{"key":"2026010700553062000_12.2.e001608.10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2478\/rir-2023-0029","article-title":"Correlations of baseline neutrophil-lymphocyte ratio with prognosis of patients with lupus nephritis: A single-center experience","volume":"4","author":"Chen","year":"2023","journal-title":"Rheumatol Immunol Res"},{"key":"2026010700553062000_12.2.e001608.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2010.07.009"},{"key":"2026010700553062000_12.2.e001608.12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/RHU.0000000000000273","article-title":"Efficacy and Safety of Rituximab in Systemic Lupus Erythematosus and Sj\u00f6gren Syndrome Patients With Refractory Thrombocytopenia: A Retrospective Study of 21 Cases","volume":"21","author":"Jiang","year":"2015","journal-title":"J Clin Rheumatol"},{"key":"2026010700553062000_12.2.e001608.13","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.121368"},{"key":"2026010700553062000_12.2.e001608.14","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1080\/14737159.2019.1665511","article-title":"Role of anti-DNA auto-antibodies as biomarkers of response to treatment in systemic lupus erythematosus patients: hypes and hopes. Insights and implications from a comprehensive review of the literature","volume":"19","author":"Bragazzi","year":"2019","journal-title":"Expert Rev Mol Diagn"},{"key":"2026010700553062000_12.2.e001608.15","doi-asserted-by":"crossref","first-page":"103479","DOI":"10.1016\/j.autrev.2023.103479","article-title":"Recommendations for the use of anti-dsDNA autoantibodies in the diagnosis and follow-up of systemic lupus erythematosus - A proposal from an expert panel","volume":"22","author":"Rojo","year":"2023","journal-title":"Autoimmun Rev"},{"key":"2026010700553062000_12.2.e001608.16","first-page":"31","article-title":"Anti-dsDNA antibody avidity determination by a simple reliable ELISA method for SLE diagnosis and monitoring","volume":"12","author":"Villalta","year":"2003","journal-title":"Lupus (Los Angel)"},{"key":"2026010700553062000_12.2.e001608.17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.808008","article-title":"The Anti-DNA Antibodies: Their Specificities for Unique DNA Structures and Their Unresolved Clinical Impact-A System Criticism and a Hypothesis","volume":"12","author":"Rekvig","year":"2021","journal-title":"Front Immunol"},{"key":"2026010700553062000_12.2.e001608.18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cca.2021.12.029","article-title":"Laboratory evaluation of anti-dsDNA antibodies","volume":"528","author":"Cockx","year":"2022","journal-title":"Clin Chim Acta"},{"key":"2026010700553062000_12.2.e001608.19","first-page":"906","article-title":"Diagnosing systemic lupus erythematosus: new-generation immunoassays for measurement of anti-dsDNA antibodies are an effective alternative to the Farr technique and the Crithidia luciliae immunofluorescence test","volume":"19","author":"Antico","year":"2010","journal-title":"Lupus (Los Angel)"},{"key":"2026010700553062000_12.2.e001608.20","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/art.1780200308","article-title":"An immunofluorescent method using Crithidia luciliae to detect antibodies to double-stranded DNA","volume":"20","author":"Crowe","year":"1977","journal-title":"Arthritis Rheum"},{"key":"2026010700553062000_12.2.e001608.21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.04801.x"},{"key":"2026010700553062000_12.2.e001608.22","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/902821","article-title":"Clinical comparison of QUANTA Flash dsDNA chemiluminescent immunoassay with four current assays for the detection of anti-dsDNA autoantibodies","volume":"2015","author":"Infantino","year":"2015","journal-title":"J Immunol Res"},{"key":"2026010700553062000_12.2.e001608.23","first-page":"864","article-title":"International multi-center evaluation of a novel chemiluminescence assay for the detection of anti-dsDNA antibodies","volume":"25","author":"Bentow","year":"2016","journal-title":"Lupus (Los Angel)"},{"key":"2026010700553062000_12.2.e001608.24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.5858\/arpa.2024-0057-OA","article-title":"Clinical Performance of the Line Immunoassay and Digital Liquid Chip Method for Detecting Autoimmune Liver Disease Autoantibodies","volume":"149","author":"Lv","year":"2025","journal-title":"Arch Pathol Lab Med"},{"key":"2026010700553062000_12.2.e001608.25","doi-asserted-by":"crossref","first-page":"566","DOI":"10.5858\/arpa.2022-0331-OA","article-title":"Clinical Performance of the Line Immunoassay, Digital Liquid Chip Method, and Chemiluminescent Immunoassay for Detecting Specific Antinuclear Antibodies","volume":"148","author":"Su","year":"2024","journal-title":"Arch Pathol Lab Med"},{"key":"2026010700553062000_12.2.e001608.26","doi-asserted-by":"publisher","DOI":"10.1002\/art.27584"},{"key":"2026010700553062000_12.2.e001608.27","first-page":"35","article-title":"American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren\u2019s syndrome","volume":"69","author":"Shiboski","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2026010700553062000_12.2.e001608.28","first-page":"403","article-title":"Detection of antibodies to dsDNA: an overview of laboratory assays","volume":"15","author":"Rouquette","year":"2006","journal-title":"Lupus (Los Angel)"},{"key":"2026010700553062000_12.2.e001608.29","doi-asserted-by":"crossref","DOI":"10.1007\/s13317-017-0097-2","article-title":"Chemiluminescent immunoassay technology: what does it change in autoantibody detection?","volume":"8","author":"Cinquanta","year":"2017","journal-title":"Auto Immun Highlights"},{"key":"2026010700553062000_12.2.e001608.30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jim.2018.05.014","article-title":"The clinical utility of anti-double-stranded DNA antibodies and the challenges of their determination","volume":"459","author":"Mummert","year":"2018","journal-title":"J Immunol Methods"},{"key":"2026010700553062000_12.2.e001608.31","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-018-8992-9"},{"key":"2026010700553062000_12.2.e001608.32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10067-017-3771-x","article-title":"The performance of different anti-dsDNA autoantibodies assays in Chinese systemic lupus erythematosus patients","volume":"37","author":"Zhao","year":"2018","journal-title":"Clin Rheumatol"},{"key":"2026010700553062000_12.2.e001608.33","doi-asserted-by":"crossref","DOI":"10.1111\/sji.13220","article-title":"Comparison of current methods for anti-dsDNA antibody detection and reshaping diagnostic strategies","volume":"96","author":"Infantino","year":"2022","journal-title":"Scand J Immunol"},{"key":"2026010700553062000_12.2.e001608.34","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2023-001012","article-title":"Clinical implications of discordance between anti-dsDNA antibodies by multiplex flow immunoassay and Crithidia luciliae assay in a multiethnic racial cohort of patients with SLE","volume":"10","author":"Zaminski","year":"2023","journal-title":"Lupus Sci Med"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2025-001608","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T08:55:58Z","timestamp":1767776158000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2025-001608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,7,15]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/lupus-2025-001608"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2025-001608","relation":{},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}